Hefter H, Rosenthal D, Samadzadeh S
J Funct Morphol Kinesiol. 2025; 10(1).
PMID: 39982280
PMC: 11843869.
DOI: 10.3390/jfmk10010041.
Boulay C, Coq J, Sangeux M, Authier G, Ulian A, Pradines M
Front Rehabil Sci. 2025; 6:1454109.
PMID: 39981203
PMC: 11839612.
DOI: 10.3389/fresc.2025.1454109.
Motavasseli D, Delorme C, Bayle N, Gracies J, Roze E, Baude M
Toxins (Basel). 2024; 16(9).
PMID: 39330850
PMC: 11436131.
DOI: 10.3390/toxins16090392.
Maldonado P, Bessaguet H, Chol C, Giraux P, Lafaie L, Adham A
Toxins (Basel). 2024; 16(8).
PMID: 39195775
PMC: 11359055.
DOI: 10.3390/toxins16080365.
Lefaucheur J, Moro E, Shirota Y, Ugawa Y, Grippe T, Chen R
Clin Neurophysiol. 2024; 164:57-99.
PMID: 38852434
PMC: 11418354.
DOI: 10.1016/j.clinph.2024.05.007.
Outcomes of Pressure Sore Surgery in Patients with Spinal Cord Injury and Spasticity.
Negosanti L, Sanguinetti G, Musumeci G, Bettini F, Salucci P, Rucci P
Plast Reconstr Surg Glob Open. 2024; 12(3):e5632.
PMID: 38435462
PMC: 10906608.
DOI: 10.1097/GOX.0000000000005632.
Research Productivity among Filipino Neurologists Associated with Socioeconomic, Healthcare, and Disease Burden Factors: A Bibliometric Analysis.
Apor A, Jamora R
Int J Environ Res Public Health. 2022; 19(23).
PMID: 36497702
PMC: 9736391.
DOI: 10.3390/ijerph192315630.
Botulinum Neurotoxins in Central Nervous System: An Overview from Animal Models to Human Therapy.
Luvisetto S
Toxins (Basel). 2021; 13(11).
PMID: 34822535
PMC: 8622321.
DOI: 10.3390/toxins13110751.
Continuous Increase of Efficacy under Repetitive Injections of Botulinum Toxin Type/A beyond the First Treatment for Adult Spastic Foot Drop.
Hefter H, Nickels W, Rosenthal D, Samadzadeh S, Albrecht P
Toxins (Basel). 2021; 13(7).
PMID: 34357938
PMC: 8310361.
DOI: 10.3390/toxins13070466.
Contribution of Single-Fiber Evaluation on Monitoring Outcomes Following Injection of Botulinum Toxin-A: A Narrative Review of the Literature.
Moron H, Gagnard-Landra C, Guiraud D, Dupeyron A
Toxins (Basel). 2021; 13(5).
PMID: 34067540
PMC: 8156529.
DOI: 10.3390/toxins13050356.
Botulinum toxin type A versus anticholinergics for cervical dystonia.
Rodrigues F, Duarte G, Castelao M, Marques R, Ferreira J, Sampaio C
Cochrane Database Syst Rev. 2021; 4:CD004312.
PMID: 33852744
PMC: 8092669.
DOI: 10.1002/14651858.CD004312.pub3.
Disease Progression of Idiopathic Cervical Dystonia in Spite of Improvement After Botulinum Toxin Therapy.
Hefter H, Schomaecker I, Schomaecker M, Samadzadeh S
Front Neurol. 2020; 11:588395.
PMID: 33281726
PMC: 7689059.
DOI: 10.3389/fneur.2020.588395.
Botulinum toxin type A therapy for hemifacial spasm.
Duarte G, Rodrigues F, Castelao M, Marques R, Ferreira J, Sampaio C
Cochrane Database Syst Rev. 2020; 11:CD004899.
PMID: 33211908
PMC: 8078498.
DOI: 10.1002/14651858.CD004899.pub3.
Botulinum toxin type A therapy for blepharospasm.
Duarte G, Rodrigues F, Marques R, Castelao M, Ferreira J, Sampaio C
Cochrane Database Syst Rev. 2020; 11:CD004900.
PMID: 33211907
PMC: 8094161.
DOI: 10.1002/14651858.CD004900.pub3.
Botulinum toxin type A therapy for cervical dystonia.
Rodrigues F, Duarte G, Marques R, Castelao M, Ferreira J, Sampaio C
Cochrane Database Syst Rev. 2020; 11:CD003633.
PMID: 33180963
PMC: 8106615.
DOI: 10.1002/14651858.CD003633.pub4.
Clinical Pharmacology of Botulinum Toxin Drugs.
Dressler D
Handb Exp Pharmacol. 2020; 263:93-106.
PMID: 32886157
DOI: 10.1007/164_2019_273.
Precise quantification of the time course of voluntary activation capacity following Botulinum toxin injections in the biceps brachii muscles of chronic stroke survivors.
Chandra S, Afsharipour B, Rymer W, Suresh N
J Neuroeng Rehabil. 2020; 17(1):102.
PMID: 32703213
PMC: 7376714.
DOI: 10.1186/s12984-020-00716-z.
Painful legs and moving toes syndrome: treating movement to treat pain-a case report.
Bosco L, Falzone Y, Butera C, Bianchi F, Vezzulli P, Filippi M
J Neurol. 2020; 267(6):1852-1854.
PMID: 32372183
DOI: 10.1007/s00415-020-09878-1.
A Proposal for Botulinum Toxin Type A Injection Into the Temporal Region in Chronic Migraine Headache.
Kim Y, Bae J, Kim H, Wang S, Kim S
Toxins (Basel). 2020; 12(4).
PMID: 32231158
PMC: 7232308.
DOI: 10.3390/toxins12040214.
The Use of Botulinum Toxin for Treatment of the Dystonias.
Berardelli A, Conte A
Handb Exp Pharmacol. 2019; 263:107-126.
PMID: 31820178
DOI: 10.1007/164_2019_339.